The Affiliated Stomatological Hospital of Zunyi Medical University, Zunyi, China.
Oral Disease Research Key Laboratory of Guizhou Tertiary Institution, School of Stomatology, Zunyi Medical University, Zunyi, China.
Biomol Biomed. 2024 May 2;24(3):477-485. doi: 10.17305/bb.2023.9760.
High-mobility group box-1 protein (HMGB1) is a nonhistone chromatin-related protein widely found in eukaryotic cells. It is involved in the transcription, replication, and repair of DNA to maintain nuclear homeostasis. It participates in cell growth, differentiation, and signal transduction. Recent studies showed that HMGB1 has a bidirectional regulatory effect on tumors by regulating TLR4/MYD88/NF-κB and RAGE/AMPK/mTOR signaling pathways. On the one hand, it is highly expressed in a variety of tumors, promoting tumor proliferation and invasion, while on the other hand, it induces autophagy and apoptosis of tumor cells and stimulates tumor-infiltrating lymphocytes to produce an anti-tumor immune response. At present, HMGB1 could be used as a target to regulate the drug resistance and prognostication in cancer. Clinical applications of HMGB1 in cancer need further in-depth studies.
高迁移率族蛋白 B1(HMGB1)是一种广泛存在于真核细胞中的非组蛋白染色质相关蛋白。它参与 DNA 的转录、复制和修复,以维持核内稳态。它参与细胞的生长、分化和信号转导。最近的研究表明,HMGB1 通过调节 TLR4/MYD88/NF-κB 和 RAGE/AMPK/mTOR 信号通路对肿瘤具有双向调节作用。一方面,它在多种肿瘤中高表达,促进肿瘤增殖和侵袭,另一方面,它诱导肿瘤细胞自噬和凋亡,并刺激肿瘤浸润淋巴细胞产生抗肿瘤免疫反应。目前,HMGB1 可以作为一个靶点来调节癌症的耐药性和预后。HMGB1 在癌症中的临床应用需要进一步深入研究。